These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9019647)

  • 41. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
    Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
    Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic burden of impairment in children with severe or difficult-to-treat asthma.
    Szefler SJ; Zeiger RS; Haselkorn T; Mink DR; Kamath TV; Fish JE; Chipps BE
    Ann Allergy Asthma Immunol; 2011 Aug; 107(2):110-119.e1. PubMed ID: 21802018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Drug prescriptions and costs in diabetic polyneuropathy].
    Rathmann W; Haastert B; Giani G
    Dtsch Med Wochenschr; 1999 Jun; 124(22):681-6. PubMed ID: 10394347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cost-effectiveness studies of ambulatory educational programs for children with asthma and their families].
    Scholtz W; Haubrock M; Lob-Corzilius T; Gebert N; Wahn U; Szczepanski R
    Pneumologie; 1996 Aug; 50(8):538-43. PubMed ID: 8975245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Poor control increases the economic cost of asthma. A multicentre population-based study.
    Accordini S; Bugiani M; Arossa W; Gerzeli S; Marinoni A; Olivieri M; Pirina P; Carrozzi L; Dallari R; De Togni A; de Marco R
    Int Arch Allergy Immunol; 2006; 141(2):189-98. PubMed ID: 16899987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the cost of albuterol inhalers in the Michigan and California Medicaid Programs: a total cost-of-care approach.
    Tierce JC; Meller W; Berlow B; Gerth WC
    Clin Ther; 1989; 11(1):53-61. PubMed ID: 2655905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cost analysis of clinical treatment of polytrauma patients].
    Ruchholtz S; Nast-Kolb D; Waydhas C; Stuber R; Lewan U; Schweiberer L
    Chirurg; 1995 Jul; 66(7):684-92. PubMed ID: 7671756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of asthma therapy: a comprehensive review.
    Domínguez-Ortega J; Phillips-Anglés E; Barranco P; Quirce S
    J Asthma; 2015; 52(6):529-37. PubMed ID: 25539023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapy changes and cost development in bronchial asthma. A 10-year retrospective study at the medical outpatient clinic of the Zurich University Hospital].
    Bregenzer T; Mössinger C; Medici TC
    Pneumologie; 1990 Aug; 44(8):960-6. PubMed ID: 1977157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment costs of peripheral arterial occlusive disease in Germany: a comparison of costs and efficacy.
    Rudofsky G; van Laak HH
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S22-5. PubMed ID: 7517472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Cost of Asthma Treatment in Phramongkutlao Hospital: Population-Based Study in Adults.
    Boonpiyathad T; Yimsawad S; Sangasapaviriya A
    J Med Assoc Thai; 2016 Jan; 99(1):51-7. PubMed ID: 27455824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methods of measuring asthma severity and influence on patient assignment.
    Lee S; Kirking DM; Erickson SR
    Ann Allergy Asthma Immunol; 2003 Nov; 91(5):449-54. PubMed ID: 14692427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Direct cost of medical treatment to the asthmatic patient in the pediatric emergency service of a medical care tier-two hospital].
    Ceballos Martínez ZI; González Mercado E; Jiménez Grandes I; Peralta Bahena ME; Tah Arias WF
    Rev Alerg Mex; 2003; 50(2):43-7. PubMed ID: 12825487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of self-managed anticoagulant therapy in Germany.
    Taborski U; Wittstamm FJ; Bernardo A
    Semin Thromb Hemost; 1999; 25(1):103-7. PubMed ID: 10327229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.
    Jacob C; Bechtel B; Engel S; Kardos P; Linder R; Braun S; Greiner W
    Eur J Health Econ; 2016 Mar; 17(2):195-201. PubMed ID: 25716136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of a structured treatment and teaching programme on asthma.
    Trautner C; Richter B; Berger M
    Eur Respir J; 1993 Nov; 6(10):1485-91. PubMed ID: 8112443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Geographic and economic aspects of inhalation therapy].
    Haidl P; Köhler D
    Pneumologie; 1999 Dec; 53(12):612-6. PubMed ID: 10684240
    [No Abstract]   [Full Text] [Related]  

  • 58. Asthma: prevalence and cost of illness.
    Stock S; Redaelli M; Luengen M; Wendland G; Civello D; Lauterbach KW
    Eur Respir J; 2005 Jan; 25(1):47-53. PubMed ID: 15640322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct medical cost of asthma in Ankara, Turkey.
    Celik GE; Bavbek S; Paşaoğlu G; Mungan D; Abadoğlu O; Harmanci E; Misirligil Z
    Respiration; 2004; 71(6):587-93. PubMed ID: 15627869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Costs of asthma treatment in Estonia.
    Kiivet RA; Kaur I; Lang A; Aaviksoo A; Nirk L
    Eur J Public Health; 2001 Mar; 11(1):89-92. PubMed ID: 11276578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.